ATX-202

ATX-202 is a polypeptide that promotes melanocyte recruitment and possesses protective and proliferative properties. These attributes make it a viable candidate for pigmentation-related research. Kythera is currently planning a clinical trial of ATX-202 in the unmet pigmentation disorder, vitiligo.